Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.22%
SPX
-0.05%
IXIC
-0.01%
FTSE
+0.46%
N225
+0.26%
AXJO
+0.02%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
283.25M
Dividend Yield
0.00%
P/E Ratio
-5.40
EPS
-0.19
Revenue
4.05M
Avg. Volume
3.06M

Recently from Cashu

publisher logo
Cashu

Ocugen (OCGN) Merges with Carisma Therapeutics to Enhance Biopharmaceutical Portfolio

12 days ago
publisher logo
Cashu

Ocugen Merges with Carisma Therapeutics to Strengthen Biopharmaceutical Capabilities

14 days ago
publisher logo
Cashu

Ocugen Secures FDA Approval for OCU410ST, Advancing to Pivotal Phase 2/3 Trial

19 days ago

About

What does OCGN do?
Ocugen is a biopharmaceutical company based in Malvern, Pennsylvania, focused on gene and cell therapies for eye diseases, including inherited retinal disorders. The company also develops inhalation-based vaccines for COVID-19 and seasonal flu.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Pennsylvania, USA
Website
http://ocugen.com
Stocks
Health Care
ocgn
Ocugen
OCGN
+0.05 (+5.15%)
1.02
USD
At close at Jul 08, 15:09 UTC
Summary
News
Signals
Benchmarks
Financials